Literature DB >> 20926633

Telomerase immortalization of principal cells from mouse collecting duct.

Stacy L Steele1, Yongren Wu, Robert J Kolb, Monika Gooz, Courtney J Haycraft, Kent T Keyser, Lisa Guay-Woodford, Hai Yao, P Darwin Bell.   

Abstract

Recently, the use of overexpression of telomerase reverse transcriptase (TERT) has led to the generation of immortalized human cell lines. However, this cell immortalization approach has not been reported in well-differentiated mouse cells, such as renal epithelial cells. We sought to establish and then characterize a mouse collecting duct cell line, using ectopic expression of mTERT. Isolated primary cortical collecting duct (CCD) cell lines were transduced with mouse (m)TERT, using a lentiviral vector. mTERT-negative cells did not survive blasticidin selection, whereas mTERT-immortalized cells proliferated in selection media for over 40 subpassages. mTERT messenger RNA and telomerase activity was elevated in these cells, compared with an SV40-immortalized cell line. Flow cytometry with Dolichos biflorus agglutinin was used to select the CCD principal cells, and we designated this cell line mTERT-CCD. Cells were well differentiated and exhibited morphological characteristics typically found in renal epithelial cells, such as tight junction formation, microvilli, and primary cilia. Further characterization using standard immunofluorescence revealed abundant expression of aquaporin-2 and the vasopressin type 2 receptor. mTERT-CCD cells exhibited cAMP-stimulated/benzamil-inhibited whole cell currents. Whole cell patch-clamp currents were also enhanced after a 6-day treatment with aldosterone. In conclusion, we have successfully used mTERT to immortalize mouse collecting duct cells that retain the basic in vivo phenotypic characteristics of collecting duct cells. This technique should be valuable in generating cell lines from genetically engineered mouse models.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926633      PMCID: PMC3006301          DOI: 10.1152/ajprenal.00183.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  40 in total

1.  Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.

Authors:  M Asamoto; N Hokaiwado; Y M Cho; S Takahashi; Y Ikeda; K Imaida; T Shirai
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

2.  Effects of genetic background on prostate and taste bud carcinogenesis due to SV40 T antigen expression under probasin gene promoter control.

Authors:  Makoto Asamoto; Naomi Hokaiwado; Young-Man Cho; Tomoyuki Shirai
Journal:  Carcinogenesis       Date:  2002-03       Impact factor: 4.944

3.  Establishment of human fibroma cell lines from a MEN1 patient by introduction of either hTERT or SV40 early region.

Authors:  R Voglauer; J Grillari; K Fortschegger; M Wieser; T Sterovsky; P Gunsberg; H Katinger; R Pfragner
Journal:  Int J Oncol       Date:  2005-04       Impact factor: 5.650

Review 4.  Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex.

Authors:  C Belgiovine; I Chiodi; C Mondello
Journal:  Cytogenet Genome Res       Date:  2009-01-30       Impact factor: 1.636

5.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

6.  Generation and in vitro differentiation of a spermatogonial cell line.

Authors:  Li-Xin Feng; Yali Chen; Luis Dettin; Renee A Reijo Pera; John C Herr; Erwin Goldberg; Martin Dym
Journal:  Science       Date:  2002-06-20       Impact factor: 47.728

7.  Developmental and tissue-specific regulation of mouse telomerase and telomere length.

Authors:  K R Prowse; C W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

Review 8.  Establishment of conditionally immortalized epithelial cell lines from the intestinal tissue of adult normal and transgenic mice.

Authors:  Robert H Whitehead; Pamela S Robinson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-24       Impact factor: 4.052

9.  hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics.

Authors:  Matthias Wieser; Guido Stadler; Paul Jennings; Berthold Streubel; Walter Pfaller; Peter Ambros; Claus Riedl; Hermann Katinger; Johannes Grillari; Regina Grillari-Voglauer
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-20

10.  Immortalized cells as experimental models to study cancer.

Authors:  Jesse S Boehm; William C Hahn
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

View more
  4 in total

1.  The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate.

Authors:  Vicki J Hwang; Jeffrey Kim; Amy Rand; Chaozhe Yang; Steve Sturdivant; Bruce Hammock; P Darwin Bell; Lisa M Guay-Woodford; Robert H Weiss
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-08

2.  Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1.

Authors:  Kyung Lee; Sylvia Boctor; Laura M C Barisoni; G Luca Gusella
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

3.  Culturing primary rat inner medullary collecting duct cells.

Authors:  Dörte Faust; Andrea Geelhaar; Beate Eisermann; Jenny Eichhorst; Burkhard Wiesner; Walter Rosenthal; Enno Klussmann; Enno Klussman
Journal:  J Vis Exp       Date:  2013-06-21       Impact factor: 1.355

4.  Cystin genetic variants cause autosomal recessive polycystic kidney disease associated with altered Myc expression.

Authors:  Chaozhe Yang; Naoe Harafuji; Amber K O'Connor; Robert A Kesterson; Jacob A Watts; Amar J Majmundar; Daniela A Braun; Monkol Lek; Kristen M Laricchia; Hanan M Fathy; Shrikant Mane; Shirlee Shril; Friedhelm Hildebrandt; Lisa M Guay-Woodford
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.